Heart Institute Physicians

Recent Publication List
1. Gruberg L., Milo S., Tzvi M., Lotan C., Merin G., Braun S., Mohr R., Tzivoni D., Bitran D., Beyar R. (2003) Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel. Isr. Med. Assoc. J. 5(8):539-42

2. Gotsman M.S., Lotan C., Mosseri M. (2003) Clinical manifestations and outcome of acute myocardial infarction in very young patients. Isr. Med. Assoc. J. 5(9):633-6.

3. Cahan A., Gilon D., Manor O., Paltiel O. (2003) Probalistic reasoning and clinical decision-making: do doctors overestimate diagnostic probabilities? QJM 96(10);763-9.

4. Gatt M.E., Liebster D., Leibowitz D., Matzner Y. (2003) Acute myocardial infarction after bone marrow transplantation: an unsuspected late complication. Ann. Hematol. 82(2):136-8.

5. Zahger D., Behar S., Harpaz D., Leor J., Weiss AT, Gottlieb S. (2003) Characteristics, management and outcome of patients with prior coronary bypass surgery presenting with acute myocardial infarction. Cardiology 99(2):105-10.

6. Alcalai R., Metzger S., Rosenheck S., Meiner V., Chajek-Shaul T. (2003) A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. J. Am. Coll. Cardiol. 16;42(2):319-27.

7. Han B., Fixler R., Beeri R., Wang Y, Bachrach U., Hasin Y. (2003) The opposing effects of endothelin-1 and C-type natriuretic peptide on apoptosis of neonatal rat cardiac myocytes. Eur. J. Pharmacol. 474(1):15-20.

8. Renbaum P., Beeri R., Gabai E., Amiel M., Gal M., Ehrengruber M.U., Levy-Lahad E. (2003) Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells. Gene 318:113-24.

9. Bimbat M., Sapoznikov D., Mosseri M., Assaf J., Bdolach-Abraham T., Vilensky L., Lotan C. (2003) Improvement in exercise test accuracy using a bayesian model. J. Isr. Heart Society 13(1):24-32.

10. Landesberg G., Mosseri M., Wolf Y.G., Bocher M., Basevitch A., Rudis E., Izhar U., Anner H., Weissman C., Berlatzky Y. (2003) Preoperative thallium scanning, selective coronary revascularization and long-term survival following major vascular surgery. Circulation 108:177-183.

11. Landesberg G., Shatz V., Akopnik I., Wolf Y.G., Mayer M., Berlatzky Y., Weissman C., Mosseri M. (2003) Association of cardiac troponin, CK-MB and postoperative myocardial ischemia with long-term survival following major vascular surgery. J. Am Coll. Cardiol. 42:1547-54.

12. Danenberg H.D., Fishbein I., Epstein H., Waltenberger J., Moerman E., Mönkkönen J, Gao J, Gathi I, Golomb G. (2003) Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon injury in the rat carotid artery. J. Cardiovasc. Pharm. 42:671-9.

13. Edelman E.R., Danenberg H.D. (2003) Rapamycin for cardiac transplant rejection and vasculopathy: One stone - Two birds? Circulation 108:6-8.

14. Danenberg H.D., Szalai A.J., Swaminathan R.V., Peng L., Chen Z., Seifert P., Fay W.P., Simon D.I., Edelman E.R. (2003) Increased thrombosis following injury in human C-reactive protein transgenic mice. Circulation 108: 512-515.

15. Muszkat M., Friedman G., Danenberg H.D., Greenbaum E., Lipo M., Heymann Y., Zakay-Rones Z., Ben-Yehuda A. (2003) Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors. Exp. Gerontol. 38:1199-203.

16. Danenberg H.D., Golomb G., Groothuis A., Gao J., Epstein H., Swaminathan R.V., Seifert P., Edelman E.R. (2003) Liposomal Alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation 108: 2798-804.

17. Gerganski P., Meerkin D., Lotan C.(2004) Distal protection of bifurcating vessels: a novel approach. Catheter. Cardiovasc. Interv. 61(4):512-4.

18. Urban P., Gershlick A.H., Guagliumi G., Guyon P., Lotan C., Schofer J., Seth A., Sousa J.E., Wijns W. (2004) The e-Cypher Registry: Objectives and organization. Ann. Cardiol. Angeiol. 53Supp1:18s-21s.

19. Gerganski P., Meerkin D., Lotan C.(2004) Distal protection of bifurcating vessels – A novel approach. Cathet. & Cardiovasc. Interv. 61:512-514.

20. Gerrah R., Fogel F., Gilon D. (2004) Aspirin decreases Vascular Endothelial Growth Factor Release During Myocardial Ischemia. Int. J. Cardiol. 94(1):25-9.

21.Gerrah R., Tshori S., Gilon D. (2004) Pericardial fluid and serum VEGF in response to different types of Heparin in treatment. Int. J. of Cardiol. 94(2-3):193-196.

22. Mehta R.H., Bossone E., Evangelista A., O’Gara P.T., Smith D.E., Cooper J.V., Oh J.K., Januzzi J.L., Hutchison S., Gilon D., Pape L.A., Nienaber C.A., Isselbacher E.M., Eagle K.A. (2004) Acute type B Aortic Dissection in elderly patients: Clinical features, outcomes and simple risk stratification. Ann. Thoracic Surg. 77:1622-9.

23. Collins J.S., Evangelista A., Nienaber C.A., Bossone E., Fang J., Cooper J.V., Smith D.E., O’Gara P.T., Myrmel T., Gilon D., Isselbacher E.M., Penn M., Pape L.A., Eagle K.A., Mehta R.H. (2004) Differences in clinical presentation, management and outcomes of acute type A aortic dissection in patients with and without prior cardiac surgery. Circulation 110(11 Suppl 1):II237-42.

24. Shibolet O., Elinav E., Admon D. et al. (2004) Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation 77(10):1576-80.

25. Pollak A., Rokach A., Blumnefeld A., Rosen L.J., Resnik L., Dresner Pollak R. (2004) Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease. Eur. Heart J. 25(3):240-5.

26. Elazary A.S., Lador N., Shauer A., Meir K., Pollak A., Wolf D.G., Raz I., Leitersdorf E., Mevorach D. (2004) Tongue necrosis and pericarditis. Lancet 363(9413):948.

27. Rubinger D., Revis N., Pollak A., Luria M.H., Sapoznikov D. (2004) Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol. Dial. Transplant 19(8):2053-60.

28. Landesberg G., Mosseri M., Shatz V.,Akopnik I., Bocher M., Mayer M., Anner H., Berlatzky Y., Weissman C. (2004) Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thalliumscanning, and coronary revascularization. J. Am. Coll. Cardiol. 44(3):569-75.

29. Mehran R., Nikolsky E., Camenzind E., Zelizko M., Kranjec I., Seabra-Gomes R., Negoita M., Slack S., Lotan C. (2005) An internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation. Am. Heart J. 2005150(6):1171-1176.

30. Dong S., Smorgick Y., Nahir M., Lotan C., Mosseri M., Nassar H., Gotsman M.S., Hasin Y. (2005) Predictors for successful angioplasty of chronic totally occluded coronary arteries. J. Interv. Cardiol. 18(1):1-7.

31. Szalat A., Durst R., Cohen A., Lotan C. (2005) Use of polytetrafluoroethylene-covered stent for treatment of coronary artery aneurysm. Cath. Cardiovasc. Interv. 66(2):203-8.

32. Rav-Acha M., Sassa D., Ilan Y., Miltager E., Lotan C. (2005) Surgical intervention in infective endocarditis – indications and timing. HaRefuah 144(6) 421-5. (Hebrew)

33. Mosseri M., Tamari I., Plich M., Hasin Y., Brizines M., Frimerman A., Miller H., Jafari J., Guetta V., Solomon M., Lotan C. (2005) Short- and Long-term Outcomes of the Titanium-NO Stent Registry. Cardiovasc. Revasc. Med. 6:2-6.

34. Cahan A., Gilon D., Manor O., Paltiel O. (2005) Clinical experience did not reduce the variance in physician's estimates of prestest probability in a cross sectional survey. J. Clin. Epidemiol. 58(11):1211-6.

35. Mehta R.H., Manfredini R., Bossone E., Hutchinson S., Evangelista A., Boari B., Cooper J.V., Smith D.E., Ogara P.T., Gilon D., Pape L.A., Nienaber C.A., Isselbacher E.M., Eagle K.A. (2005) Does circadian and seasonal variation in occurrence of acute Aortic dissection influence in-hospital outcomes. Chronobiology International: 22(2);343-351.

36. Rott D., Benhorin J., Keren A., Baras M., Leibowitz D., Banai S. (2005) Prediction of coronary artery disease severity in patients referred for coronary angiography. Clin. Cardiol. 28(6):288-92.

37. Leibowitz D. (2005) Lack of prognostic impact of elevated troponin levels in patients without coronary artery disease. J. Am. Coll. Cardiol. 46(4):740-1.

38. Leibowitz D., Planer D., Ben-Ivgi F., Weiss A.T., Bursztyn M. (2005) Tumor necrosis factor and interleukin-6 levels in hypertensive patients with and without left ventricular hypertrophy. Blood Press. 14(1):21-4.

39. Ofran Y., Leibowitz D., Gatt M., Baras M., Boukhobza R., Weiss A.T. (2005) The prognostic value of troponin T and echocardiography in acute pulmonary edema. Int. J. Cardiol. 18;99(2):247-51.

40. Nitzan M., Rosenfeld C., Weiss A.T., Grossman E., Patron A., Murray A. (2005) Effects of external pressure on arteries distal to the cuff during sphygmomanometry. IEEE Trans. Biomed. Eng. 52(6):1120-7.

41. Rokach A., Pollak A., Rosen L., Freidlander Y., Blumenfeld A., Reznik L., Dresner-Pollak R. (2005) Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. J. Clin. Endocrinol. Metab. 90(12):6556-60.

42. Mosseri M., Satler L., Pichard A., Waksman R. (2005) Impact of Vessel Calcification on Outcome after Coronary Stenting. Cardiovasc. Revasc. Med. 6(4);147-153.

43.Brzezinski A., Danenberg H.D. (2005) Estrogen, progesterone, and cardiovascular health: when shall we complete the puzzle? Menopause 12:488-91.

44. Lotan C., Almagor Y., Kuiper K., Suttorp M.J., Wijns W. (2006) Sirolimus-eluting stent in chronic total occlusion: The SICTO study. J. Interv. Card. 19(4):307-12.

45. Planer D., Leibowitz D., Paltiel O., Boukhobza R., Lotan C., Weiss T.A. (2006) The diagnostic value of troponin T testing in the community setting. Int. J. Cardiol. 107(3):369-75.

46. Strehblow C., Sperker W., Hevesi A., Garamvölgyi R., Petrasi Z., Shirazi M., Sylvén C., Weiss T., Lotan C., Pugatsch T., Ben-Sasson S.A., Orlowski M., Glogar D., Gyöngyösi M. (2006) Paradox effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent. J. Endovasc. Therapy 13(1):94-103.

47. Urban P., Gershlick A.H., Guagliumi G., Guyon P., Lotan C., Schofer J., Seth A., Sousa J.E., Wijns W., Berge C., Deme M., Stoll H.P., on behalf of the e-Cypher investigators. (2006) Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice: One-year Follow-Up of the e-Cypher Registry. Circulation 113(11):1434-41.

48. Elian D., Guetta V., Alcalai R., Lotan C., Segev A. (2006) Early mobilization after diagnostic cardiac catheterization with the use of a hemostatic bandage containing thrombin. Cardiovasc. Revasc. Med. 7(2) 61-3.

49. Pugatsch T., Abedat S., Lotan C., Beeri R. (2006) Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways. Breast Cancer Res. 8(4): R35.

50. Matot I, Shleifer A, Hersch M, Lotan C, Weiniger CF, Dror Y, Einav S. (2006) In-hospital cardiac arrest: Is outcome related to the time of arrest? Resuscitation 71(1):56-64.

51. Mosseri M, Miller H, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, Jefary J, Guetta V, Solomon M, Lotan C (2006) The Tinanium-NO stent: Results of a multicenter registry. EuroIntervention 2:192-6.

52. Grupper A., Rudin D., Drenger B., Varone D., Gilon D., Gielchinsky Y., Menashe M., Mintz Y., Rivkind A., Brezis M. (2006) Prevention of perioperative venous thromboembolism and cornary events. Differential responsiveness to an interim program to improve guidelines adherence. International Journal for Quality in Health Care 18(2):123-6.

53. Ad N., Barnett S., Lefrak E.A., Korach A., Pollak A., Gilon D., Elami A. (2006) Impact of follow-up on the success of the cryosurgical procedure in patients with rheumatic heart disease and enlarged atria. J. Thoracic. Cardiovasc. Surg. 131(5);1073-9.

54. Ben-Dov I.Z., Leibowitz D., Weiss A.T. (2006) ST-segment elevation post cardioversion: a current of injury without injury. Int. J. Cardiol. 106(2):255-6.

55. Leibowitz D., Dresner-Pollak R., Dvir S., Rokach A., Reznik L., Pollak A. (2006) Association of an estrogen receptor-alpha gene polymorphism with leftventricular mass. Blood Press. 15(1):45-50.

56. Hasin T., Leibowitz D., Antopolsky M., Chajek-Shaul T. (2006) The Use of Low-Dose Insulin in Cardiogenic Shock dueto Combined Overdose of Verapamil, Enalapril and Metoprolol. Cardiology 106(4):233-236.

57. Leibowitz D., Cohen M., Planer D., Mosseri M., Rott D., Lotan C., Weiss A.T. (2006) Comparison of cardiovascular risk of noncardiac surgery following coronary angioplasty with versus without stent. Am. J. Cardiol. 97(8): 1188-91.

58. Ben-Dov I.Z., Leibowitz D., Weiss A.T. (2006) ST-segment elevation post cardioversion: a current of injury without injury. Int. J. Cardiol. 106(2):255-6.

59. Cohen M.J., Pollak A., Weiss A.T., Brezis M. (2006) Availability bias in themanagement of myocardial infarction.QJM 99(1):64-5.

60. Rott D., Weiss A.T., Chajek-Shaul T., Leibowitz D. (2006) ST-deviation patterns in recurrent myocardial infarctions. Am. J. Cardiol. 98(1):10-3.

61. Yosefy C., Berman M., Beeri R. (2006) Cusp tear in bicuspid aortic valve possibly caused by phentermine. Int. J. Cardiol. 106(2):262-3.

62. Yosefy C., Beeri R., Reisin L. (2006) Imagring silent type A aortic dissection. Isr. Med. Assoc. J. 8(1):75.

63. Raphael J., Abedat S., Rivo J., Meir K., Beeri R., Pugatsch T., Zuo Z., Gozal Y. (2006) Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J. Pharmacol. Exp. Ther. 318(1):186-94.

64. Mosseri M., Enrique Z., Fisman, Tenenbaum A. (2006) Type 2 diabetes mellitus and cardiovascular diseases: Evaluation, treatment and prevention strategies. Harefuah 145 (2);141-6. (Hebrew)

65. Shochat M., Charach G., Meyler S., Kazatzker M., Mosseri M., Rabinovich P., Shotan A., Meisel S. (2006) Internal thoracic impedance monitoring: A newmethod for early detection of cardiogenic pulmonary congestion at the pre-clinical stage. Cardiovasc. Revasc. Med. 7(1):41-51.

66. Shochat M., Charach G., Meyler S., Meisel S., Pelled B., Weintraub M., Mengeritsky G., Mosseri M., Rabinovich P. (2006) A new method for detecting pre-clinical cardiogenic pulmonary edema. Intensive Care Med. 32(8):1432-1238.

67.Vitrella G., Sangiorgi G., Kornowski R., Mosseri M., Almagor Y., Ischinger T., Pavlidis G., Rodermann J., Bartorelli A., Wijns W., Grube E., Colombo A. (2006) FX Minirail catheter usage for treatment of de-novo complex coronary lesions: Results from the OFFAR registry. J. Interv. Cardiol. 19(3):250-7.

68. Cohen-Sela E., Rosenzweig O., Gao J., Epstein H., Gati I., Reich R., Danenberg H.D., Golomb G. (2006) Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. J. Control Release Jun 12;113(1):23-30.

69. Yaron G., Brill A., Dashevsky O., Yosef-Levi I.M., Grad E., Danenberg H.D., Varon D. (2006) C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis. Br. J. Haematol. 134(4):426-31.

70. Durst R., Jansen A., Erez G., Bravdo R., Butbul E., Ben Avi L., Shpitzen S., Lotan C., Leitersdorf E., Defesche J., Friedlander Y., Meiner V., Miserez A.R. (2006) The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients. Atherosclerosis 189(2):443-50

71. Alcalai R., Planer D., Culhaoglu A., Osman A., Pollak A., Lotan C. (2007) Acute coronary syndrome vs. non specific troponin elevation, clinical predictors and survival analysis. Arch. Internal Med. 167:276-81.

72. Alcalai R., Viola N., Mosseri M., Beeri R., Leibowitz D., Lotan C., Gilon D. (2007) The value of PCI in patients with symptomatic aortic stenosis and coronary artery disease. Am. J. Med. 120(2):185.e7-13.

73. Leibowitz D., Planer D., Ben-Ibgi F., Rott D., Weiss A.T., Bursztyn M. (2007) Measurement of wall thickness alone does not accurately assess the presence of left ventricular hypertrophy. Clin. Exp. Hypertens. 29(2):119-25.

74. Gotsman I., Lotan C., Soskolne W.A., Rassovsky S., Pugatsch T., Lapidus L., Novikov Y., Masrawa S., Stabholz A. (2007)(Periodontal destruction is associated with coronary artery disease and periodontal infection with acute coronary syndrome. J. Periodontology 78(5): 849-858.

75.Jabara R., Namouz S., Kark J.D., Lotan C. (2007) Risk characteristics of Palestinian and Israeli women coronary heart disease patients in Jerusalem. Isr. Med. Assoc. J. 9(4):316-320.

76. Danenberg H.D., Kantak N., Grad E., Swaminathan R.V., Lotan C. (2007) C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur. J. Haematol. 78(3):246-52.

77. Haber G., Vitberg G., Danenberg H.D. (2007) Air pollution and cardiovascular disease. HaRefuah 146(10):738-43 (Hebrew)

78. Mor Yosef-Levy I., Grad E., Danenberg H.D. (2007) C-reactive protein: Marker or modulator for cardiovascular risk? HaRefuah 146(12):970-3. (Hebrew)

79. Grad E., Golomb M., Koroukhov N., Mor-Yosef I., Lotan C., Edelman E.R., Danenberg H.D. (2007) Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity following vascular injury. Am. J. Physiol. 293(1):H489-95.

80. Durst R., Lotan C., Nassar H., Gotsman M., Mor E., Varshitzki B., Gerganski P., Jabara R., Admon D., Meerkin D., Mosseri M. (2007) Comparison of 4 & 6 French catheters for coronary angiography: Real world modeling. Isr. Med. Assoc. J. 9:290-293.

81. Abramowitz Y., Hiller N., Perlman G., Admon D., Beeri R., Chajek-Shaul T., Leibowitz D. (2007) The diagnosis of primary cardiac lymphoma by right heart catheterization and biopsy using fluoroscopic and transthoracic echocardiographic guidance. Int. J. Cardiol. 18(2):e39-40.

82. Danenberg HD, Shauer A, Gilon D. (2007) Very late coronary stent graft thrombosis after aspirin cessation. Int. J. Cardiol. 120(1):e15-7. (Case report)

83. Durst R., Danenberg H., Gallily R., Mehoulam R., Meir K., Grad E., Beeri R., Pugatsch T., Tarsish E., Lotan C. (2007) Cannabidiol, a nonpsychoactive Cannabis constitutent, protects against myocardial ischemic reperfusion injury. Am. J. Physiol. Heart. Circ. Physiol. 293(6):H3602-7.

84. Leibowitz D, Planer D, Chajek-Shaul T. (2007) Echocardiographic manifestations of Adamantiades-Behcet's disease. Eur. J. Echocardiogr. 8(6):457-62.

85. Beeri R., Streckenbach S.., Isselbacher E.M., Akins C.W., Vlahakes G.J., Adams M.S., Levine R.A. (2007) The crossed swords sign: insights into the dilemman of repair in bileaflet mitral valve prolapse. J. Am. Soc. Echocardiogr. 20(6):698-702.

86. Beeri R, Yosefy C, Guerrero JL, Nesta F, Abedat S, Chaput N, del Monte F, Handschumacher MD, Stroud R, Sullivan S, Pugatsch T, Gilon D, Vlahakes GJ, Spinale FG, Hajjar RJ, Levine RA. (2007) Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study. Circulation 116(suppl I):I·288-I·293.

87. Jain A.K., Meredith I.T., Lotan C., Rothman M.T., Pateraki S. (2007). Real-world safety and efficacy of the Endeavor zotarolimus-eluting stent: early data from the E-Five Registry. Am. J. Cardiol. 100(8B):77M-83M.

88. Leibowitz D., Planer D., Weiss T., Rott D. (2007) Seasonal Variation in Myocardial Infarction Is Limited to Patients with ST-Elevations on Admission. Chronobiol. Int.; 24(6):1241-7.

89. Leibowitz D., Planer D., Rott D., Elitzur Y., Chajek-Shaul T., Weiss A.T. (2007) Brain Natriuretic Peptide Levels Predict Perioperative Events in Cardiac Patients Undergoing Noncardiac Surgery: A Prospective Study. Cardiology. 12; 110(4):266-270

90. Bogot N.R., Durst R., Shaham D, Admon D. (2007) Cardiac CT of the transplanted heart: indications, technique, appearance, and complications. Radiographics. 27(5):1297-1309. (Review)

91. Yosef-Levi I.M., Grad E., Danenberg H.D. (2007) C-reactive protein and atherothrombosis – a prognostic factor or a risk factor? HaRefuah 146(12):970-4, 996. (Hebrew)

92. Epstein H., Grad E., Golomb M., Koroukhov N., Edelman E.R., Golomb G., Danenberg H.D. (2008) Innate immunity has a dual effect on vascular healing: Suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge. Atherosclerosis Jul;199(1):41-6.

93. Abu-Fanne R., Brzezinski A., Golomb M., Grad E., Foldes A.J., Shufaro Y., Varon D., Brill A., Lotan C., Danenberg H.D. (2008) Effects of raloxifene and estradiol on arterial thrombosis in ovariectomized mice. Menopause 15(1):98-104.

94. Planer D., Beyar R., Almagor Y., Banai S., Guetta V., Miller H., Kornowski R., Brandes S., Krakover R., Solomon M.,Lotan C. (2008) Long-term (>3 years) outcome and predictor of clinical events after insertion of Sirolimus-eluting stent in one or more native coronary arteries (From the Israeli arm of the e-Cypher registry). Am. J. Cardiol. 101(7):953-9.

95. Beeri R., Yosefy C., Guerrero J.L., Nesta F., Abedat S., Chaput N., del Monte F., Handschumacher M.D., Stroud R., Sullivan S., Pugatsch T., Gilon D., Vlahakes G.J., Spinale F.G., Hajjar R.J., Levine R.A. (2008) Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J. Am. Coll. Cardiol. 51(4):476-86.

96. Danenberg H.D., Lotan C., Varshitsky B., Rosenheck S., Weiss A.T. (2008) Removal of contrast medium from the coronary sinus during coronary angiography: feasibility of a simple and available technique for the prevention of nephropathy. Card. Revasc. Med. 9:9-13.

97. Danenberg H.D., Grad E., Swaminathan R.V., Chen Z., Seifert P., Szalai A.J., Lotan C., Simon D.I., Edelman E.R. (2008) Neointimal dormation is reduced after arterial injury in human CRP transgenic mice. Atherosclerosis [Epub ahead of print 2008 Feb13]

98. Shuvy M., Shifman O.E., Nusair S., Pappo O., Lotan C. (2008) Hypothyroidism-induced myocardial damage and heart failure: an overlooked entity. Cardiovasc. Pathol. [Epub ahead of print 2008 Feb 21].

99. Brzezinski A., Danenberg H.D. (2008) Sex hormones, soy and myocardial injury. Menopause 15(2):217-20.

100. Rott D., Greganski P., Nowatzky J., Weiss A.T., Chajek-Shaul T., Leibowitz D. (2008) ST deviation pattern in acute myocardial infarction is not related to lesion location. J. Thromb. Thrombolysis [Epub ahead of print 2008 Jan 11].

101. Raphael J., Zuo Z., Abedat S., Beeri R., Gozal Y. (2008) Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology 108(3):415-25

102. Bulut A., Rav-Acha M., Aydin O., Arin C.B., Beeri R., Danenberg H.D. (2008) “Inverted Tako-Tsubo”: Transient apical-sparing cardiomyopathy. Int. J. Cardiol. 134(1):e35-8. (Case report)

103. Eliakim-Raz N., Shuvy M., Lotan C., Planer D. (2008) Psoriasis and dilated cardiomyopathy: Coincidence or related diseases? Cardiology 111(3):202-206.

104. Raphael J., Zuo Z., Abedat S., Beeri R., Gozal Y. (2008) Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology 108(3):415-25.

105. Gotsman I., Stabholz A., Planer D., Pugatsch T., Lapidus L., Novikov Y., Masrawa S., Soskolne A., Lotan C.(2008) Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden? Isr. Med. Assoc. J. 10(7):494-8.

106. Gotsman I., Zwas D., Planer D., Azaz-Lifshits T., Admon D., Lotan C., Keren A. (2008) Clinical outcome of patients with heart failure and preserved left ventricular function. Am. J. Med. 121(11):997-1101.

107. Afergan E., Epstein H., Dahan R., Koroukhov N., Rohekar K., Danenberg H.D., Golomb G. (2008) Delivery of serotonin to the brain by monocytes following phagocytosis of lipisomes. J. Control. Release 132(2):84-90.

108. Shuvy M., Abedat S., Beeri R., Danenberg H.D., Planer D., Ben-Dov I.Z., Meir K., Sosna J., Lotan C. (2008) Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats. Cardiovasc Res 1;79(3):492-9.

109. Epstein H., Gutman D., Cohen-Sela E., Haber E., Elmalak O., Koroukhov N., Danenberg H.D., Golomb G. (2008) Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization. A.A.P.S. J. 10(4):505-15.

110. Leibowitz D, Abu-Gazala M, Katz I,Danenberg H, Nassar H, Boguslavsky L, Mosseri M, Varshitzky B, Lotan C, Weiss AT. (2009) Computerized gradual balloon inflation: a novel strategy of coronary angioplasty superior to a standard manual approach. Cardiovasc Revasc Med 10(1)45-8.

111. Rosenheck S., Sharon Z., Weiss A. (2009) Long-term follow-up of patients with relatively high effective defibrillation threshold during cardioverter defibrillator implantation with endocardial leads. Cardiology 112(2):107-13.

112. Rosenheck S, Gomi S, Katz I, Rabin A, Shpoliansky U, Mandelbaim M, Weiss AT. (2009) Modified alternating current defibrillation: a new defibrillation technique. Europace 11(2):239-244.

113. Rosenheck S. (2009) The desmosome in the epidermis and myocardium. Cardiology 113(1):25-7.

114. Nassar H., Gotsman I., Gerganski P., Moseri M., Lotan C., Gotsman M. (2009) Cutting balloon angioplasty and stent implantation for aorto-ostial lesions: Clinical outcome and 1-year follow-up. Clin CArdiol 32(4):183-6.

115. Leibowitz D., Lotan C., Katz I., Nassar H., Boguslavsky L., Mosseri M., Jabara R., Varshitzky B., Danenberg H., Weiss A.T. (2009) Effect of gradual computerized angioplasty on outcomes of patients undergoing coronary stenting. Am J Cardiol 104(2):223-6.

116. Zwirn G., Beeri R., Gilon D., Friedman Z., Akselrod S. (2009) Quantitative evaluation of local myocardial blood volume in contrast echocardiography.

117. Grad E., Golomb M., Koroukhov N., Lawson J.N., Lotan C., Fitzgerald G.A., Danenberg H.D. (2009) Aspirin reduces the prothrombotic activity of C-reactive protein. J Thrombosis Haemostasis 7(8):1393-400.

118. Rosenheck S., Weiss A., Sharon Z. (2009) Therapy success and survival in patients with valvular heart disease and implantable cardioverter defibrillator. Int J Cardiol

119. Shuvy M., Shifman O.E., Nusair S., Pappo O., Lotan C. (2009) Hypothyroidism-induced myocardial damage and heart failure: an overlooked entity. Cardiovasc Pathol 18(3):183-6.

120. Durst R., Neumark Y., Meiner V., Friedlander Y., Sharon N., Polak A., Beeri R., Danenberg H., Erez G., Spitzen S., Ben-Avi L., Leitersdorf E., Lotan C. (2009) Increased risk for atherosclerosis of various macrophage scavenger receptor 1 alleles. Genet Test Mol Biomarkers 13(5):583-7.

121. Danenberg H.D., Marincheva G., Varshitzki B., Nassar H., Lotan C. (2009) Stent thrombosis: a poor man’s disease? Isr Med Assoc J 11(9):529-32.

122. Lotan C., Meredith I.T., Mauri L., Liu M., Rothman M.T. (2009) Safety and effectiveness of the Endavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry. J Am Coll Cardiol Intv 2:1227-35.

123. Shuvy M., Ben Ya-acov A., Zolotarov L., Lotan C., Ilan Y. (2009) Beta glycosphingolipids rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification. Int J Immunopathol Pharmacol 22(4):911-8.

124. Rosenheck S. (2009) Arrhythmogenicity of the Purkinje system: a new step toward understanding ventricular fibrillation. Heart Rhythm 6(12):1782-9.

125. Durst R., Bogot N., Gilon D., Drenger B. Potential role for coronary computerized angiography for assessing perioperative risk. J Cardiothorac Vasc Anesth 2010 April; 24(2):348-55.

126. Rosenheck S. (2010) The genetic background of arrhythmogenic right ventricular myopathy: It’s not so simple. Cardiology 115(2):145-7.

127. Durst R., Goldstein K., Horowitz Y., Baggish A., Gare M., Hasin Y., Lotan C., Horowitz M. Hypothyroid dependent myocardial angiotensin receptor trafficking is involved in improved cardiac performance after heat acclimation. Life Sci 2010 27;86(9-10):331-6.

128. Jain A.K., Lotan C., Meredith I.T., Feres F., Zambahari R., Sinha N., Rothman M.T. Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: Results from the E-Five Registry. Heart 2010;96:848-853.

129. Danenberg H.D. Prior bare metal stent restenosis as a predictor for subsequent restenosis: the lightning often strikes twice. Cardiology 2010;116(3):188-9.

130. Gotsman I., Zwas D., Planer D., Admon D., Lotan C., Keren A. The significance of serum urea and renal function in patients with heat failure. Medicine (Baltimore) 2010 Jul; 89(4):197-203.

131. Beeri R., Chaput M., Guerrero J.L., Kawase Y., Yosefy C., Abedat S., Karakikes I., Morel C., Tisosky A., Sullivan S., Handschumacher M.D., Gilon D., Vlahakes G.J., Hajjar R.J., Levine R.A. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circ Heart Fail 2010 Sep1; 3(5):627-34.

132. Shuvy M., Nyska A., Beeri R., Abedat S., Gal-Moscovici A., Rajamannan N., Lotan C. Histopathology and apoptosis in an animal model of reversible renal failure. Exp Toxicol Pathol. (E-pub ahead of print)

133. Durst R., Lotan C. The potential for clinical use of cannabinoids in treatment of cardiovascular disease. Cardiovasc Ther (E-pub ahead of print)

134. Hellman Y., Varshitzky B., Danenberg H.D. The role of 3-D CT angiography reconstruction in the diagnosis of vascular closure device complications. Int J Cardiol (E-pub ahead of print)

135. Planer D., Elitzur E., Lev I., Sharon N., Ouzan E., Pugatsch T., Chasid M., Rom M., Lotan C. Bupropion for smoking cessation in patients with acute coronary syndrome. Arch Int Med (accepted)